Bank of Montreal
BCAB icon

Bank of Montreal’s BioAtla BCAB Stock Holding History

Bank of Montreal’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,470
Closed -$43.4K – 3493
2024
Q4 		$43.4K Sell
1,470
-10,445
-88% -$877K ﹤0.01% 3137
2024
Q3 		$971K Buy
11,915
+3,831
+47% +$321K ﹤0.01% 2061
2024
Q2 		$627K Buy
8,084
+2,870
+55% +$341K ﹤0.01% 2281
2024
Q1 		$907K Sell
5,214
-798
-13% -$99.1K ﹤0.01% 2060
2023
Q4 		$866K Buy
6,012
+1,632
+37% +$141K ﹤0.01% 2132
2023
Q3 		$508K Buy
4,380
+4,058
+1,260% +$517K ﹤0.01% 2445
2023
Q2 		$62.2K Buy
322
+100
+45% +$17.2K ﹤0.01% 3555
2023
Q1 		$30.6K Buy
+222
New +$40K ﹤0.01% 3454
2021
Q2 		– Sell
-7
Closed -$17K – 3759
2021
Q1 		$17K Buy
+7
New +$17.9K ﹤0.01% 4113

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Bank of Montreal's BCAB Position: Q1 2025 in Review

Bank of Montreal sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 1,470 shares — an estimated $43.4K sold.

Bank of Montreal first reported a position in BCAB in Q1 2021 and held it in 9 quarters. The position peaked at $971K in Q3 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

  • Bank of Montreal reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
  • Bank of Montreal sold 1,470 BioAtla shares in Q1 2025, an estimated $43.4K.
  • Bank of Montreal first reported a position in BioAtla in Q1 2021 and held it in 9 quarters.
  • Bank of Montreal's BioAtla position peaked at $971K in Q3 2024.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.